CVS Health Corp. buy Barclays PLC
Summary
This prediction ended on 08.11.25 with a price of €68.62. The prediction had a final performance of 25.08%. Barclays_PLC has a follow-up prediction for CVS Health Corp. where he still thinks CVS Health Corp. is a Buy. Dividends of €0.64 are taken into consideration when calculating the performance. Barclays_PLC has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CVS Health Corp. | -12.235% | -12.235% | 11.884% |
| iShares Core DAX® | 1.130% | 2.184% | 15.737% |
| iShares Nasdaq 100 | 1.128% | -0.611% | 7.324% |
| iShares Nikkei 225® | 2.610% | 4.958% | 20.446% |
| iShares S&P 500 | -0.006% | -0.952% | 2.166% |
Comments by Barclays_PLC for this prediction
In the thread CVS Health Corp. diskutieren
In the thread Trading CVS Health Corp.